SCHEDULE 13G/A

4D Molecular Therapeutics Inc

Common Stock, par value $0.0001 per share · CUSIP: 35104E100

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Deep Track Capital, LP

  Shares: 609,900.00 · Class: 1.32%

• Deep Track Biotechnology Master Fund, Ltd.

  Shares: 609,900.00 · Class: 1.32%

• David Kroin

  Shares: 609,900.00 · Class: 1.32%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.